LeadIQ logo
Learn more at LeadIQ.com

Insights

Multinational Presence HiFiBiO Therapeutics operates globally with offices in Cambridge, MA, Paris, Hong Kong, Shanghai, and Hangzhou, providing diverse geographical sales opportunities.

Clinical Expertise Recognition Being recognized as a 'Fierce 15' biotech company in 2023 showcases HiFiBiO's strong clinical expertise, creating credibility and trust for potential sales engagements.

Innovative Product Development Developing single-cell microfluidics with the potential to transform immunotherapy treatments positions HiFiBiO as a cutting-edge provider, opening doors for innovative solutions sales.

Strategic Partnerships Collaboration with major pharmaceutical and biotech companies aligns HiFiBiO with industry leaders, paving the way for strategic partnership-based sales opportunities.

Series D Funding Success Securing $75M in Series D financing accentuates HiFiBiO's financial stability and growth trajectory, indicating potential for investment in their products and services.

Similar companies to HiFiBiO Therapeutics

HiFiBiO Therapeutics Tech Stack

HiFiBiO Therapeutics uses 8 technology products and services including Google Font API, ADP, jQuery, and more. Explore HiFiBiO Therapeutics's tech stack below.

  • Google Font API
    Font Scripts
  • ADP
    Human Resource Management System
  • jQuery
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • Google Maps
    Maps
  • Microsoft
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Apache
    Web Servers

Media & News

HiFiBiO Therapeutics's Email Address Formats

HiFiBiO Therapeutics uses at least 1 format(s):
HiFiBiO Therapeutics Email FormatsExamplePercentage
F.Last@hifibio.comJ.Doe@hifibio.com
81%
Last@hifibio.comDoe@hifibio.com
10%
First.Last@hifibio.comJohn.Doe@hifibio.com
5%
FirstL@hifibio.comJohnD@hifibio.com
4%

Frequently Asked Questions

Where is HiFiBiO Therapeutics's headquarters located?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics's main headquarters is located at 237 Putnam Ave Cambridge, Massachusetts 02139 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is HiFiBiO Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics's official website is hifibio.com and has social profiles on LinkedIn.

How much revenue does HiFiBiO Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, HiFiBiO Therapeutics's annual revenue reached $35M.

What is HiFiBiO Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does HiFiBiO Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, HiFiBiO Therapeutics has approximately 81 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: R. A.Chief Scientific Officer: F. A.Head Of Translational And Clinical Data Science: J. P.. Explore HiFiBiO Therapeutics's employee directory with LeadIQ.

What industry does HiFiBiO Therapeutics belong to?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics operates in the Biotechnology Research industry.

What technology does HiFiBiO Therapeutics use?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics's tech stack includes Google Font APIADPjQueryTensorFlowGoogle MapsMicrosoftYoast SEOApache.

What is HiFiBiO Therapeutics's email format?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics's email format typically follows the pattern of . Find more HiFiBiO Therapeutics email formats with LeadIQ.

How much funding has HiFiBiO Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, HiFiBiO Therapeutics has raised $141M in funding. The last funding round occurred on Jun 14, 2021 for $75M.

When was HiFiBiO Therapeutics founded?

Minus sign iconPlus sign icon
HiFiBiO Therapeutics was founded in 2013.
HiFiBiO Therapeutics

HiFiBiO Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for immunotherapies. DIS® combines unique single-cell capabilities with AI/ML approaches using patient samples to discover novel targets, effective antibody drugs, and predictive biomarkers. With DIS®, HiFiBiO gains an unprecedented understanding of immune modulation in human diseases driving a robust clinical pipeline of transformative immunotherapies. Additionally, HiFiBiO has partnered with major multinational pharmaceutical and biotech companies applying its innovative DIS® approach.

HiFiBiO Therapeutics is headquartered in Cambridge, MA with additional operations in Paris, France, Hong Kong, Shanghai, and Hangzhou, China.

Section iconCompany Overview

Headquarters
237 Putnam Ave Cambridge, Massachusetts 02139 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $141M

    HiFiBiO Therapeutics has raised a total of $141M of funding over 2 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $75Mas a Series D.

  • $10M$50M

    HiFiBiO Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $141M

    HiFiBiO Therapeutics has raised a total of $141M of funding over 2 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $75Mas a Series D.

  • $10M$50M

    HiFiBiO Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.